FDA Inspection 727926 — NYU Langone Health, Transplantation & Cellular Therapy

NYU Langone Health, Transplantation & Cellular Therapy — FEI 2470026

The FDA completed an inspection of NYU Langone Health, Transplantation & Cellular Therapy on June 21, 2011 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 21, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)

Citations

IDCFRDescription
311821 CFR 820.75(a)Documentation
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
908921 CFR 600.14(c)When to report